Long circulation liposome with modified integrin and carried anticancer medicine for injection
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- PEKING UNIV
- Publication Date
- 2006-10-18
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The invention relates to the technical field of pharmaceutical preparations, in particular to a targeted liposome drug delivery system loaded with anticancer drugs for injection. The system uses polyethylene glycol (PEG) and A high-efficiency liposome drug delivery system obtained by modifying integrin ligands containing arginine-glycine-aspartic acid sequence (RGD) or RGD analogues. Background technique
[0002] Malignant tumors have always been an important disease that plagues human beings, and there is currently no cure for cancer. The traditional therapy for malignant solid tumors is surgical resection of the tumor followed by chemotherapy with antineoplastic drugs. Most chemotherapeutic drugs are non-selective, and these drugs also have a killing effect on normal cells while killing tumor cells, so they will produce serious side effects, such as the cardiotoxic effect of doxorubicin. Encapsulating anticancer drugs with liposomes can significant...